Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist-Reference-Cited by-同舟云学术

Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist

Published:2009-02 Issue:2 Volume:26 Page:230-240
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Denker Andrew E.,Morelli Gaetano,Vessey Laura K.,Li Susie,Yuan Jinyu,Dunbar Stephanie,Lewis Nicole M.,Taggart William,Wagner John A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-009-0003-z.pdf

Reference22 articles.

1. Snel S, Jansen JA, Pedersen PC, Jonkman JH, van Heiningen PN. Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin. Eur J Clin Pharmacol. 1998;54:355–357.

2. Reuning RH, Geraets DR. Digoxin. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied Pharmacokinetics: Principles of Therapeutics Drug Monitoring. 2nd edition. Spokane, WA: Applied Therapeutics Inc; 1986:570–623.

3. Awni WM, Hussein Z, Cavanaugh JH, Granneman GR, Dube LM. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans. Clin Pharmacokinet. 1995;29(suppl. 2):92–97.

4. Harder S, Thurmann PA. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers. Br J Clin Pharmacol. 1997;43:475–480.

5. World Health Organization. Obesity fact sheet No. 311. Available at: www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed January 1, 2009.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–Drug Interactions of the Nonsteroidal Mineralocorticoid Receptor Antagonist Apararenone With Midazolam, Warfarin, and Digoxin: A Phase 1 Studies in Healthy Volunteers;Clinical Therapeutics;2020-11

2. The effect of maraviroc on the pharmacokinetics of digoxin in healthy volunteers;Clinical Pharmacology in Drug Development;2014-02-06

3. Covalent Drug-Protein Adducts: An Exploration of Their Role in Drug-Induced Liver and General Organ Toxicity;Encyclopedia of Drug Metabolism and Interactions;2012-10-15

4. Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects;Biopharmaceutics & Drug Disposition;2011-11-24

5. Effects of Laropiprant, a Selective Prostaglandin D2Receptor 1 Antagonist, on the Steady-State Pharmacokinetics of Digoxin in Healthy Adult Subjects;The Journal of Clinical Pharmacology;2010-07